Used in pharmaceutical research as a kinase inhibitor, particularly in the development of targeted cancer therapies. Shows activity against tyrosine kinases involved in tumor growth and proliferation. Investigated for potential use in treating solid tumors and hematologic malignancies due to its ability to selectively inhibit signaling pathways in cancer cells. Also employed in structure-activity relationship (SAR) studies to optimize potency and selectivity in drug design.